arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Septerna, Inc.

SEPN
$47.44 ▼ -0.44 (-0.92%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
15 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Septerna, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.1B
Dividend Yield —
Revenue Growth 22375.6% ↗
Op. Margin -62.9% ↘
ROIC -4.7% ↘
FCF / Share $-0.49 ↗
Trailing P/E —
Price / Book 5.6x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

15-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$26.75M
↑ +22375.6% —
Net Income Profit after all expenses
$-8.64M
↑ +59.8% —
Operating Margin Operating profit as % of sales
-62.9%
↓ -25.5% 1th
FCF / Share Free cash flow per share
$-0.49
↓ -6.9% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
35
Returns ↓
32
Cash Quality ↑
6

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters